Efficacy and Safety of 20 mg (2 Tablets of 10mg)VAC BNO 1095 FCT on Cyclic Mastodynia and PMS

NCT01870687 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Premenstrual Syndrome
Mastodynia

Interventions

DRUG: 20mg VAC BNO 1095 FCT
DRUG: Placebo

Sponsor

Bionorica SE